• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球晚期/转移性乳腺癌分析:十年报告(2005-2015 年)。

Global analysis of advanced/metastatic breast cancer: Decade report (2005-2015).

机构信息

European School of Oncology, Lisbon, Portugal; Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.

Breast Cancer Network Australia, Camberwell, Australia.

出版信息

Breast. 2018 Jun;39:131-138. doi: 10.1016/j.breast.2018.03.002. Epub 2018 Apr 19.

DOI:10.1016/j.breast.2018.03.002
PMID:29679849
Abstract

Approximately 0.5 million people worldwide die from metastatic breast cancer (mBC) every year. This manuscript provides an overview on the status of mBC in several regions of the world, highlighting the gaps in care, resources, and support available for patients with mBC. Primary research was conducted in 2015 and 2016, comprising four global qualitative and quantitative surveys of approximately 15,000 individuals in 34 countries. Secondary research was conducted using literature reviews of peer-reviewed publications, patient survey reports, and media or online articles. There have been modest improvements in mBC outcomes over the past decade. Patients are not provided with adequate information about mBC. There is a need for open discussion with patients and caregivers about realistic goals; however, physicians are not trained in communicating with patients about their disease. Maintaining patients' quality of life is a crucial goal; however, this has not improved, and in some cases, may have declined in the past decade. Public awareness and understanding of mBC is limited, with damaging consequences for patients and caregivers. Issues affecting employment remain relevant to patients with mBC and their caregivers. Globally, mBC is associated with a substantial economic burden. Relationships with caregivers are crucial to patients with mBC, and caregiver support needs are often overlooked. A strong and united global effort among healthcare professionals, including clinicians, oncologists, pharmaceutical manufacturers, payers, and policy makers, and with advocates, families, and patients, is necessary to improve the outcome and quality of life for patients with mBC.

摘要

全世界每年约有 50 万人死于转移性乳腺癌(mBC)。本文概述了世界上几个地区的 mBC 现状,重点介绍了 mBC 患者护理、资源和支持方面的差距。主要研究于 2015 年和 2016 年进行,包括对 34 个国家约 15000 人的四项全球定性和定量调查。辅助研究使用了同行评议出版物、患者调查报告以及媒体或在线文章的文献综述。在过去的十年中,mBC 的治疗结果略有改善。但患者并未获得关于 mBC 的充分信息。需要与患者和护理人员就现实目标进行公开讨论,但医生并未接受过关于如何与患者讨论疾病的培训。维持患者的生活质量是一个关键目标,但这并没有得到改善,在某些情况下,过去十年中可能有所下降。公众对 mBC 的认识和理解有限,这对患者和护理人员都有严重的影响。影响就业的问题仍然与 mBC 患者及其护理人员有关。在全球范围内,mBC 给患者带来了沉重的经济负担。与护理人员的关系对 mBC 患者至关重要,但护理人员的支持需求经常被忽视。医疗保健专业人员(包括临床医生、肿瘤学家、制药制造商、支付者和政策制定者)以及倡导者、家庭和患者之间需要进行强有力的、全球性的合作,以改善 mBC 患者的治疗结果和生活质量。

相似文献

1
Global analysis of advanced/metastatic breast cancer: Decade report (2005-2015).全球晚期/转移性乳腺癌分析:十年报告(2005-2015 年)。
Breast. 2018 Jun;39:131-138. doi: 10.1016/j.breast.2018.03.002. Epub 2018 Apr 19.
2
Understanding the Needs of Patients with Metastatic Breast Cancer: Results of the Make Your Dialogue Count Survey.了解转移性乳腺癌患者的需求:“让您的对话有价值”调查结果
Breast J. 2017 Jan;23(1):17-25. doi: 10.1111/tbj.12675. Epub 2016 Sep 13.
3
Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey.监测全身治疗期间转移性乳腺癌的争议。GIM(意大利乳腺小组)调查的结果。
Breast. 2018 Aug;40:45-52. doi: 10.1016/j.breast.2018.04.011. Epub 2018 Apr 19.
4
Outcomes research examining treatments, quality of life and costs in HER2-negative and triple-negative metastatic breast cancer: a systematic literature review.研究 HER2 阴性和三阴性转移性乳腺癌治疗、生活质量和成本的结果:系统文献回顾。
J Comp Eff Res. 2018 Jan;7(1):67-83. doi: 10.2217/cer-2017-0027. Epub 2018 Jan 5.
5
Patient-Reported Outcome Measures to Improve the Care Continuum for Patients With Metastatic Breast Cancer: Opportunities and Implications for Nursing Practice.患者报告结局测量指标在改善转移性乳腺癌患者护理连续性中的应用:对护理实践的机遇与启示。
Semin Oncol Nurs. 2023 Dec;39(6):151510. doi: 10.1016/j.soncn.2023.151510. Epub 2023 Oct 12.
6
The economic burden of metastatic breast cancer: a systematic review of literature from developed countries.转移性乳腺癌的经济负担:来自发达国家的文献系统评价。
Cancer Treat Rev. 2011 Oct;37(6):405-15. doi: 10.1016/j.ctrv.2010.12.008. Epub 2011 Apr 8.
7
Financial burden among metastatic breast cancer patients: a qualitative inquiry of costs, financial assistance, health insurance, and financial coping behaviors.转移性乳腺癌患者的经济负担:对成本、经济援助、健康保险和经济应对行为的定性研究。
Cancer Causes Control. 2024 Jun;35(6):955-961. doi: 10.1007/s10552-024-01854-8. Epub 2024 Feb 22.
8
Re-imagining metastatic breast cancer care delivery: a patient-partnered qualitative study.重新构想转移性乳腺癌护理提供方式:一项患者伙伴关系的定性研究。
Support Care Cancer. 2023 Nov 30;31(12):735. doi: 10.1007/s00520-023-08201-8.
9
Incidence-based cost-of-illness model for metastatic breast cancer in the United States.美国转移性乳腺癌基于发病率的疾病成本模型。
Int J Technol Assess Health Care. 2012 Jan;28(1):12-21. doi: 10.1017/S026646231100064X.
10
Living with metastatic breast cancer (LIMBER): experiences, quality of life, gaps in information, care and support of patients in the UK.英国转移性乳腺癌患者的生活体验(LIMBER):患者的生活质量、信息、护理和支持方面的差距。
Support Care Cancer. 2023 Jul 11;31(8):459. doi: 10.1007/s00520-023-07928-8.

引用本文的文献

1
Association between advanced lung cancer inflammation index and distant metastasis in breast cancer: a retrospective cohort study.晚期肺癌炎症指数与乳腺癌远处转移之间的关联:一项回顾性队列研究。
Front Oncol. 2025 Aug 19;15:1613346. doi: 10.3389/fonc.2025.1613346. eCollection 2025.
2
Safety Profile and Predictors of Adverse Events of Incadronate Disodium in Treating Breast Cancer Patients with Bone Metastases: A Retrospective Study.因卡膦酸二钠治疗乳腺癌骨转移患者的安全性及不良事件预测因素:一项回顾性研究
Breast Cancer (Dove Med Press). 2025 Aug 20;17:727-739. doi: 10.2147/BCTT.S523392. eCollection 2025.
3
Comparative long-term outcomes of first-line CDK4/6 inhibitors plus endocrine therapy versus endocrine therapy in patients with HR+/HER2-metastatic or advanced breast cancer: a meta-analysis.
一线CDK4/6抑制剂联合内分泌治疗与内分泌治疗用于HR+/HER2-转移性或晚期乳腺癌患者的比较长期结局:一项荟萃分析。
Front Pharmacol. 2025 Jul 25;16:1600892. doi: 10.3389/fphar.2025.1600892. eCollection 2025.
4
Promotion of the invasion and metastasis of breast cancer by B7-H3 through CCR5High tumor-associated macrophages.B7-H3通过CCR5高表达的肿瘤相关巨噬细胞促进乳腺癌的侵袭和转移
Cancer Cell Int. 2025 Aug 4;25(1):293. doi: 10.1186/s12935-025-03932-6.
5
Health-related quality of life and physical activity collected via mobile application and wearable device in patients with HR +/HER2 - advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone: 6-month longitudinal study (JBCRG-26).通过移动应用程序和可穿戴设备收集的接受哌柏西利联合内分泌治疗或单纯内分泌治疗的HR +/HER2 - 晚期乳腺癌患者的健康相关生活质量和身体活动情况:6个月纵向研究(JBCRG-26)
Breast Cancer. 2025 Jul 18. doi: 10.1007/s12282-025-01744-0.
6
Time and location of specialty palliative care for women dying with metastatic breast cancer.转移性乳腺癌临终女性患者专科姑息治疗的时间和地点。
Breast Cancer Res Treat. 2025 Jul 15. doi: 10.1007/s10549-025-07780-w.
7
"The disease and its treatment make you less of a woman": self-reported experiences of women with breast cancer receiving care in Kumasi, Ghana.“疾病及其治疗让你不再像个女人”:加纳库马西乳腺癌女性患者的自我报告经历
Support Care Cancer. 2025 Jul 10;33(8):677. doi: 10.1007/s00520-025-09744-8.
8
Underserved Patient Populations With Metastatic Breast Cancer: A Review of Progress and Remaining Challenges.转移性乳腺癌患者的医疗服务不足群体:进展与尚存挑战综述
Breast J. 2025 Jun 30;2025:2461234. doi: 10.1155/tbj/2461234. eCollection 2025.
9
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial.HER2阴性晚期乳腺癌患者中预防赛托珠单抗戈维汀相关中性粒细胞减少和腹泻的研究(PRIMED):一项开放标签、单臂、2期试验
EClinicalMedicine. 2025 Jun 18;85:103309. doi: 10.1016/j.eclinm.2025.103309. eCollection 2025 Jul.
10
Size and Treatment Outcomes of HR+, HER2- Early Breast Cancer Population With High Risk of Recurrence: A Real-World Cohort Study With Danish Breast Cancer Cooperative Group Registry Data.复发高风险的HR +、HER2 -早期乳腺癌人群的肿瘤大小与治疗结局:一项基于丹麦乳腺癌协作组登记数据的真实世界队列研究
J Health Econ Outcomes Res. 2025 Jun 24;12(1):252-260. doi: 10.36469/001c.137277. eCollection 2025.